Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
Sara Alkner(Lund University), Mårten Fernö(Lund University)
Cited by 11
Related Papers
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
|PLoS ONE|2019|72
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
|Breast Cancer Research and Treatment|2019|9